Search research articles
Contact Us
Filters
Showing results (121-130 of 242) with videos related to
Page
of 25
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 12, 2009
Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C
Zobair M Younossi, Arian Afendy, Maria Stepanova, et al.
JHEP Reports : Innovation in Hepatology
|
July 25, 2022
Corrigendum to 'Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B' [JHEP Reports 3 (2021)]
Maria Buti, Maria Stepanova, Adriana Palom, et al.
Journal of Clinical Gastroenterology
|
August 28, 2018
Factors Associated With Potential Progressive Course of Primary Biliary Cholangitis: Data From Real-world US Database
Zobair M Younossi, Maria Stepanova, Pegah Golabi, et al.
JHEP Reports : Innovation in Hepatology
|
May 27, 2021
Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B
Maria Buti, Maria Stepanova, Adriana Palom, et al.
Hepatology (Baltimore, Md.)
|
January 29, 2015
Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials
Zobair M Younossi, Maria Stepanova, Patrick Marcellin, et al.
Medicine
|
November 19, 2016
The levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin (RBV)
Pegah Golabi, Elzafir Elsheikh, Azza Karrar, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 1, 2018
Long-term Effects of Treatment for Chronic HBV Infection on Patient-Reported Outcomes
Zobair M Younossi, Maria Stepanova, Issah Younossi, et al.
The Lancet. Gastroenterology & Hepatology
|
April 14, 2017
Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial
Zobair M Younossi, Maria Stepanova, Michael Charlton, et al.
Digestion
|
September 18, 2010
Association of serum adipocytokines with hepatic steatosis and fibrosis in patients with chronic hepatitis C
Ancha Baranova, Mohammed H Jarrar, Maria Stepanova, et al.
Plos One
|
February 14, 2013
Knowledge-based identification of soluble biomarkers: hepatic fibrosis in NAFLD as an example
Sandra Page, Aybike Birerdinc, Michael Estep, et al.
Page
of 25
Search research articles
Search
Showing results (121-130 of 242) with videos related to
Sort By:
Page
of 25
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 12, 2009
Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C
Zobair M Younossi, Arian Afendy, Maria Stepanova, et al.
JHEP Reports : Innovation in Hepatology
|
July 25, 2022
Corrigendum to 'Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B' [JHEP Reports 3 (2021)]
Maria Buti, Maria Stepanova, Adriana Palom, et al.
Journal of Clinical Gastroenterology
|
August 28, 2018
Factors Associated With Potential Progressive Course of Primary Biliary Cholangitis: Data From Real-world US Database
Zobair M Younossi, Maria Stepanova, Pegah Golabi, et al.
JHEP Reports : Innovation in Hepatology
|
May 27, 2021
Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B
Maria Buti, Maria Stepanova, Adriana Palom, et al.
Hepatology (Baltimore, Md.)
|
January 29, 2015
Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials
Zobair M Younossi, Maria Stepanova, Patrick Marcellin, et al.
Medicine
|
November 19, 2016
The levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin (RBV)
Pegah Golabi, Elzafir Elsheikh, Azza Karrar, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 1, 2018
Long-term Effects of Treatment for Chronic HBV Infection on Patient-Reported Outcomes
Zobair M Younossi, Maria Stepanova, Issah Younossi, et al.
The Lancet. Gastroenterology & Hepatology
|
April 14, 2017
Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial
Zobair M Younossi, Maria Stepanova, Michael Charlton, et al.
Digestion
|
September 18, 2010
Association of serum adipocytokines with hepatic steatosis and fibrosis in patients with chronic hepatitis C
Ancha Baranova, Mohammed H Jarrar, Maria Stepanova, et al.
Plos One
|
February 14, 2013
Knowledge-based identification of soluble biomarkers: hepatic fibrosis in NAFLD as an example
Sandra Page, Aybike Birerdinc, Michael Estep, et al.
Page
of 25